Blastic CD56+ Natural Killer-cell Lymphoma with Primary Cutaneous Manifestation

Acta Dermato-Venereologica

Volumn 84, Issue 1, 2004, Pages 53-56

  Berger, Thomas G ^a   Voll, Reinhard E ^a   Simon Jr , Miklos ^a   Kiesewetter, Franklin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cytotoxic lymphoma; Lymphoma classification; NK cells

Indexed keywords

CD56 ANTIGEN;

AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CYTOTOXIC T LYMPHOCYTE; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; LYMPHOMA; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; SKIN MANIFESTATION; T CELL LYMPHOMA; TUBERCULOSIS;

AGED; ANTIGENS, CD56; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, LYMPHOBLASTIC; MALE; SKIN NEOPLASMS;

EID: 0842307540     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310005889     Document Type: Article

References (18)

1. Jaffe E, Harris N, Stein H, Vardiman J. WHO classification of tumors: pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
2. Russel-Jones R. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology. J Am Acad Dermatol 2003; 48: 93-102.
3. Natkunam Y, Smoller BR, Zehnder JL, Dorfman RF, Warnke RA. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol 1999; 23: 571-581.
4. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999; 40: 850-856.
5. Ginarte M, Abalde MT, Peteiro C, Fraga M, Alonso N, Toribio J. Blastoid NK cell leukemia/lymphoma with cutaneous involvement. Dermatology 2000; 201: 268-271.
6. Amo Y, Yonemoto K, Ohkawa T, Sasaki M, Isobe Y, Sugimoto K, et al. CD56 and terminal deoxynucleotidyl transferase positive cutaneous lymphoblastic lymphoma. Br J Dermatol 2000; 143: 666-668.
7. Slater DN. Cutaneous CD56 natural killer and natural killer-like T-cell lymphoma: Editorial comments. Br J Dermatol 2000; 142: 853-855.
8. Hofbauer GFL, Kamarachev J, Kempf W, Burg G, Pestalozzi BC, Dummer R. A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations. Br J Dermatol 2001; 144: 432-434.
9. Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program) 2001; 259-281.
10. Ling TC, Harris M, Craven NM. Epstein-Barr virus-positive blastoid nasal T/natural killer-cell lymphoma in a Caucasian. Br J Dermatol 2002; 146: 700-703.
11. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
12. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
13. Shabrawi-Caelen L, Cerroni L, Sterry W, Audring H, Kerl H. Cytotoxic lymphomas. Hautarzt 2000; 51: 390-395.
14. Chim CS, Ooi GC, Shek TWH, Liang R, Kwong YL. Lethal midline granuloma revisited: nasal T natural-killer cell lymphoma. J Clin Oncol 1999; 17: 1322-1325.
15. Chiang AKS, Chan ACL, Srivastava G, Ho FCS. Nasal T natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 1997; 73: 332-338.
16. Dummer R, Potoczna N, Haffner AC, Zimmermann DR, Gilardi S, Burg G. A primary cutaneous non-T, non-B CD4(+), CD56(+) lymphoma. Arch Dermatol 1996; 132: 550-553.
17. Bastian BC, Ott G, Muller-Deubert S, Brocker EB, Muller-Hermelink HK. Primary cutaneous natural killer/T-cell lymphoma. Arch Dermatol 1998; 134: 109-111.
18. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989; 169: 2233-2238.